Publications by authors named "Christopher P Cannon"

100Publications

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.

N Engl J Med 2020 Sep 23. Epub 2020 Sep 23.

From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston (C.P.C.); AdventHealth Translational Research Institute, Orlando, FL (R.P.); the University of Tennessee Health Science Center, Memphis (S.D.-J.); Pfizer, Groton, CT (J.M., U.M., R.F., S.G.T.); Merck, Kenilworth, NJ (S.H., I.G.); the Department of Endocrinology, University of Nantes, Nantes, France (B.C.); Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey, New Brunswick (W.J.S.); Pfizer, Berlin (S.G.); the Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, Stockholm (F.C.); the University of Toronto, Toronto (D.Z.I.C); and the University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2004967DOI Listing
September 2020

Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.

Eur Heart J 2020 Aug 21. Epub 2020 Aug 21.

Brigham and Women's Hospital, Cardiovascular Innovation, 360 Longwood Ave, 7th Floor, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehaa550DOI Listing
August 2020

Time-Dependent Cardiovascular Treatment Benefit Model for Lipid-Lowering Therapies.

J Am Heart Assoc 2020 Aug 28;9(15):e016506. Epub 2020 Jul 28.

Imperial Centre for Cardiovascular Disease Prevention Department of Primary Care and Public Health Imperial College London England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.120.016506DOI Listing
August 2020

Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis.

Thromb Res 2020 Jul 9;195:128-135. Epub 2020 Jul 9.

University of Connecticut/Hartford Hospital Evidence-based Practice Center, Hartford, CT, USA; School of Medicine, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2020.07.010DOI Listing
July 2020

Novel Oral Anticoagulants Following Percutaneous Coronary Intervention.

Circ Cardiovasc Interv 2020 Jul 15;13(7):e008465. Epub 2020 Jul 15.

Department of Medicine, University of North Carolina at Chapel Hill (B.Q.A., M.A.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.119.008465DOI Listing
July 2020

The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.

Diabetes Obes Metab 2020 May 21. Epub 2020 May 21.

Cardiovascular Division, The George Institute for Global Health, UNSW, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.14091DOI Listing
May 2020

Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk.

Am J Cardiol 2020 05 4;125(10):1577-1581. Epub 2020 Mar 4.

Brigham and Women's Hospital Cardiovascular Division and Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2020.01.053DOI Listing
May 2020

Low-Density Lipoprotein Cholesterol: Lower Is Totally Better.

J Am Coll Cardiol 2020 May 21;75(17):2119-2121. Epub 2020 Mar 21.

Prevention Section, Cardiovascular Division, Brigham & Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.03.033DOI Listing
May 2020

Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply.

JAMA Cardiol 2020 Feb;5(2):235-236

Duke Clinical Research Institute; Duke University, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2019.5241DOI Listing
February 2020

Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes.

J Am Coll Cardiol 2019 12 9;74(24):3013-3022. Epub 2019 Dec 9.

Thrombolysis In Myocardial Infarction Study Group, Brigham and Women's Hospital, Cardiovascular Division, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.09.065DOI Listing
December 2019

Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States.

Am Heart J 2020 01 31;219:70-77. Epub 2019 Oct 31.

Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO, USA; The George Institute for Global Health and University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.10.014DOI Listing
January 2020

Don't stop the statin!

Eur Heart J 2019 11;40(43):3526-3528

Cardiovascular Innovation, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz629DOI Listing
November 2019

Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.

J Am Coll Cardiol 2019 08;74(8):1057-1068

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.06.038DOI Listing
August 2019

Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.

ESC Heart Fail 2019 08 3;6(4):784-792. Epub 2019 Jul 3.

Cardiology Division, Massachusetts General Hospital, 32 Fruit Street, Yawkey 5984, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12455DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676450PMC
August 2019

Alteration of medical therapy in patients with heart failure relative to change in symptom severity.

ESC Heart Fail 2019 10 3;6(5):1085-1087. Epub 2019 Jul 3.

Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, GRB-800, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816058PMC
October 2019

Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.

J Am Coll Cardiol 2019 05;73(19):2439-2450

Departments of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.02.059DOI Listing
May 2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

N Engl J Med 2019 06 14;380(24):2295-2306. Epub 2019 Apr 14.

From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) - all in Australia; Imperial College London (B.N.) and the Department of Renal Medicine, UCL Medical School (D.C.W.) - both in London; the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H., D.Z.); the Nephrology Division, NYU School of Medicine and NYU Langone Medical Center, New York (D.M.C.); Baim Institute for Clinical Research (D.M.C., C.P.C., B.M.B.), the Cardiovascular Division (C.P.C.) and the Renal Division and Department of Medicine (B.M.B), Brigham and Women's Hospital, and Harvard Medical School (B.M.B.) - all in Boston; Janssen Research and Development, Raritan, NJ (R.E., S. Bull, G.C., P.-L.C., Y.Y., G.M.); Indiana University School of Medicine and Veterans Affairs Medical Center, Indianapolis (R.A.); the Department of Medicine, University of Chicago Medicine, Chicago (G.B.); the Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City (T.G.); the Division of Nephrology, University of British Columbia, Vancouver (A.L.), and the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.) - all in Canada; the Renal Division, Peking University First Hospital, Beijing (H.Z.); and the Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1811744
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1811744DOI Listing
June 2019

Medication Discontinuation in the IMPROVE-IT Trial.

Circ Cardiovasc Qual Outcomes 2019 01;12(1):e005041

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541480PMC
January 2019

Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry.

Diabetes Obes Metab 2019 05 14;21(5):1121-1127. Epub 2019 Feb 14.

University of California, Irvine School of Medicine, Irvine, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13625DOI Listing
May 2019

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).

Am J Cardiol 2019 02 6;123(3):382-391. Epub 2018 Nov 6.

Department of Medicine and ASH Comprehensive Hypertension Center University of Chicago, The University of Chicago School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.10.035DOI Listing
February 2019

Should real-world evidence be incorporated into regulatory approvals?

Expert Opin Drug Saf 2018 12 14;17(12):1155-1159. Epub 2018 Nov 14.

d International Centre for Circulatory Health, NHLI , Imperial College London , London , UK.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14740338.2018.1
Publisher Site
http://dx.doi.org/10.1080/14740338.2018.1546842DOI Listing
December 2018

Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Eur Heart J 2019 01;40(2):218-219

Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, 75 Francis St, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy679DOI Listing
January 2019

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome.

J Am Heart Assoc 2018 10;7(20):e009077

1 TIMI Study Group Division of Cardiovascular Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/JAHA.118.009077
Publisher Site
http://dx.doi.org/10.1161/JAHA.118.009077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474969PMC
October 2018

WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management.

Am J Cardiol 2018 Aug 16. Epub 2018 Aug 16.

Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.08.020DOI Listing
August 2018

Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status.

Am J Cardiol 2018 11 4;122(9):1451-1458. Epub 2018 Aug 4.

Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.07.034DOI Listing
November 2018

The Evolving Future of PCSK9 Inhibitors.

J Am Coll Cardiol 2018 07 9;72(3):314-329. Epub 2018 Jul 9.

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.04.054DOI Listing
July 2018

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.

Int J Cardiol 2018 Nov 26;270:245-252. Epub 2018 May 26.

Harvard Medical School, Boston, MA, United States; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.05.087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139264PMC
November 2018

Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial.

Diabetes Care 2018 07 30;41(7):1510-1515. Epub 2018 May 30.

Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-0109DOI Listing
July 2018

Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events.

Curr Cardiol Rep 2018 05 25;20(7):55. Epub 2018 May 25.

Cardiovascular Division, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-018-0997-4DOI Listing
May 2018

A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial.

JACC Clin Electrophysiol 2018 05 20;4(5):580-588. Epub 2017 Dec 20.

Baim Institute for Clinical Research, Boston, Massachusetts; Brigham & Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacep.2017.11.005DOI Listing
May 2018

Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial.

Am J Med 2018 07 23;131(7):813-819.e5. Epub 2018 Mar 23.

International Diabetes Center, Park-Nicollet Clinic, Minneapolis, Minn.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.02.023DOI Listing
July 2018

Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome.

Eur J Prev Cardiol 2018 05 14;25(8):830-838. Epub 2018 Mar 14.

1 TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487318763897DOI Listing
May 2018

Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.

Kidney Int 2018 06 8;93(6):1397-1408. Epub 2018 Mar 8.

Department of Hypertension, Medical University of Lodz, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2017.12.011DOI Listing
June 2018